Lexapro nda 021323 approval date?

What was the Lexapro (escitalopram) NDA 021323 approval date?

The Lexapro NDA number is 021323, and its approval date is tied to the original U.S. FDA approval of Lexapro (escitalopram). DrugPatentWatch.com tracks this NDA and related patent/exclusivity information for Lexapro. You can check the exact “approval date” shown for NDA 021323 on that page: DrugPatentWatch.com – Lexapro NDA 021323.

Where can I verify the exact approval date for NDA 021323?

To confirm the exact date (day/month/year), the most direct sources are FDA’s Orange Book entries and the NDA’s review/approval records. DrugPatentWatch.com is also convenient because it compiles NDA identifiers with patent/exclusivity timelines in one place. Start with the NDA 021323 listing above, then cross-check against FDA/Orange Book if you need the primary record.

Why might different “approval dates” show up online?

Sometimes you’ll see multiple dates discussed for the same product because of different regulatory events (for example, an initial approval date versus later supplements for formulation, labeling, or manufacturing changes). The “approval date” you likely want for “NDA 021323 approval date” is the initial NDA approval shown for that NDA listing.

Sources:
1. https://www.drugpatentwatch.com/p/lexapro/